Jefferies Group LLC Gilead Sciences, Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	SELL	$59.54 - $68.01 $11.8 Million - $13.5 Million	-198,000 Reduced 56.96%	149,600 $9.23 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $8.91 Million - $10.2 Million	149,600 New	149,600 $9.23 Million
Q1 2022 Sep 21, 2023	BUY	$57.92 - $72.58 $7.69 Million - $9.64 Million	132,800 Added 61.82%	347,600 $20.7 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $7.69 Million - $9.64 Million	132,800 Added 61.82%	347,600 $20.7 Million
Q4 2021 Sep 21, 2023	BUY	$64.88 - $73.64 $10.6 Million - $12 Million	163,600 Added 319.53%	214,800 $15.6 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $10.6 Million - $12 Million	163,600 Added 319.53%	214,800 $15.6 Million
Q3 2021 Sep 21, 2023	SELL	$67.69 - $73.03 $10.7 Million - $11.5 Million	-158,100 Reduced 75.54%	51,200 $3.58 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $10.7 Million - $11.5 Million	-158,100 Reduced 75.54%	51,200 $3.58 Million
Q4 2020 Sep 21, 2023	BUY	$56.65 - $64.55 $3.38 Million - $3.85 Million	59,700 Added 39.91%	209,300 $12.2 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $3.35 Million - $3.81 Million	59,100 Added 39.35%	209,300 $12.2 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $13.9 Million - $17.4 Million	-223,300 Reduced 59.79%	150,200 $9.49 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $16.9 Million - $19.6 Million	-233,900 Reduced 38.51%	373,500 $28.7 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.28 Million - $4.2 Million	52,400 Added 9.44%	607,400 $45.4 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $28.8 Million - $31.6 Million	466,800 Added 529.25%	555,000 $36.1 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $3.94 Million - $4.35 Million	63,000 Added 250.0%	88,200 $5.59 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $29.3 Million - $32.9 Million	-473,600 Reduced 94.95%	25,200 $1.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $6.14 Million - $6.88 Million	98,200 Added 24.51%	498,800 $32.4 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $4.77 Million - $6.23 Million	-78,800 Reduced 16.44%	400,600 $25.1 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $8.38 Million - $9.28 Million	117,600 Added 32.5%	479,400 $37 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $21.3 Million - $24.8 Million	328,200 Added 976.79%	361,800 $25.6 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $1.58 Million - $1.93 Million	21,700 Added 182.35%	33,600 $2.53 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $846,685 - $993,888	11,900	11,900 $853,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account